About First Ascent Biomedical
About First Ascent Biomedical
First Ascent is a biotech start-up founded in 2018 with a mission to transform medical oncology through highly individualized, prospective treatment planning technologies that improve survival and advance science.
First Ascent is a biotech start-up founded in 2018 with a mission to transform medical oncology through highly individualized, prospective treatment planning technologies that improve survival and advance science.
“When I lost my son to cancer, I knew there had to be better solutions. I understood that each patient is unique and realized each treatment should match the patient’s disease, but cancer treatment today is a recipe book. First Ascent is changing that.”
Jim Foote, CEO
Our Co-Founder’s Story
My son Trey was an amazing kid. He loved everything a 16-year-old should love. Trey was diagnosed with Bone Cancer, and he fought hard through surgery and chemo.
When it came back, I was shocked when the doctors said, “We’re sorry, we’ve given it the best we’ve got. We’re out of options. What would you like to do?”
“What would I like to do?” I thought this was a medical problem. I’m a technology executive. I did my research. I learned that Trey’s treatment protocol hadn’t changed in 25 years. I learned there were no promising treatments available. I learned the hard way that when your cancer comes back, there are often few effective options left.
I couldn’t solve this problem to save my son. That’s why we started First Ascent.
The First Ascent Difference
Our first-in-kind product, service and technology solutions package – our Drug Prediction Platform – is the First Ascent difference.
Our Team
Our Experienced Advisors
Publication and Pharma Partners
